According to the recommendations of experts, during increased incidence of COVID-19 and influenza, people at risk are not protected against infection caused by Streptococcus Pneumoniae bacteria. The changes introduced by the Ministry of Health will definitely benefit patients.
Patients over 65 years of age will be reimbursed for the 13-valent pneumococcal vaccine (Prevenar 13). with an increased (moderate to high) risk of pneumococcal disease, i.e. with: chronic heart disease, chronic liver disease, chronic lung disease, diabetes, cochlear implant, cerebrospinal fluid leakage, congenital or acquired asplenia, sickl...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].